---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-039352"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2026-04-02T23:59:59+00:00"
generated_at: "2026-05-15T07:50:01.148858+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma acquires QwikAgents software and domains for 2.1M shares

## Summary
- Asset purchase agreement with Many Ads Inc. for QwikAgents web application and domain names (qwikagents.com, .ai, .co).
- Consideration: 2,100,000 unregistered shares of Silo Pharma common stock, issued under Section 4(a)(2) exemption.
- Agreement includes customary representations, warranties, and indemnification provisions; liability capped at Purchase Price.
- Software includes Next.js/React portal and MCP server; open-source components disclosed (LGPL dependency noted).
- Transaction closed on March 30, 2026; domain transfer pending registrar processing.

## SEC filing metadata
- accession: 0001213900-26-039352
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2026-04-02T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390026039352/0001213900-26-039352-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390026039352/ea0284319-8k_silo.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-039352
- JSON: https://secwatch.observer/filing/0001213900-26-039352.json
- Plain text: https://secwatch.observer/filing/0001213900-26-039352.txt

## Source-grounded claims
- claim_id: 0f87e89ae9d166bc7394bcfa0f3cf022a2973375
  claim: Silo Pharma, Inc. entered into Agreement with Many Ads Inc. (effective 2025-07-29).
  evidence_excerpt: On July 29, 2025, Silo Pharma, Inc. (the “Company”) entered into an asset purchase agreement (the “Agreement”) with Many Ads Inc. (the “Seller”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1514183/000121390026039352/0001213900-26-039352-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.